Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibrx Biosciences (INBX) Free Cash Flow: 2023-2024

Historic Free Cash Flow for Inhibrx Biosciences (INBX) over the last 2 years, with Dec 2024 value amounting to -$197.0 million.

  • Inhibrx Biosciences' Free Cash Flow fell 10.83% to -$33.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$143.4 million, marking a year-over-year increase of 32.83%. This contributed to the annual value of -$197.0 million for FY2024, which is 0.45% up from last year.
  • According to the latest figures from FY2024, Inhibrx Biosciences' Free Cash Flow is -$197.0 million, which was up 0.45% from -$197.9 million recorded in FY2023.
  • In the past 5 years, Inhibrx Biosciences' Free Cash Flow ranged from a high of -$197.0 million in FY2024 and a low of -$197.9 million during FY2023.
  • In the last 2 years, Inhibrx Biosciences' Free Cash Flow had a median value of -$197.5 million in 2023 and averaged -$197.5 million.
  • Data for Inhibrx Biosciences' Free Cash Flow shows a peak YoY grew of 0.45% (in 2024) over the last 5 years.
  • Over the past 2 years, Inhibrx Biosciences' Free Cash Flow (Yearly) stood at -$197.9 million in 2023, then grew by 0.45% to -$197.0 million in 2024.